Poniard Pharmaceuticals Inc (OTC Pink - No Information:PARD)
| 0.0871 Delayed Data As of May 12 |  +0.0361 / +70.78%Today’s Change | 0.03 Today|||52-Week Range 0.12 | +163.94% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $87.2K |
Company Description
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.
Contact Information
Poniard Pharmaceuticals, Inc. 300 Elliott Avenue West Seattle Washington 98119 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| There are no executives to display. |
